Skip to content

Life Sciences

Innovative solutions spanning global real-world data (RWD), analytics, and technology enable confident decision-making and faster innovation.

Let’s talk

Supporting a range of R&D and commercial needs

Whether you’re in clinical development, preparing for launch, or assessing post-approval impact, tap into the world’s most extensive patient data, analytics, and tech-driven solutions to inform evidence-based decisions every step of the way. 

  1. Discovery
    • Patient & disease understanding
    • Biomarker development
    • Target identification
  2. Clinical development
    • Trial design: Inclusion / exclusion & endpoints
    • Target product profiling
  3. Regulatory approval
    • Natural history of disease
    • Treatment pathways
    • Unmet needs
  4. HTA / market access
    • Burden of disease
    • Cost of illness
    • Healthcare resource utilization
    • External control arm
    • Outcomes studies
    • Comparative effectiveness
    • RWE on treatment patterns across geographies and patient subgroups
  5. Post-launch
    • RWE supporting conditional approval
    • RWE enhancing brand value proposition
    • RWE on treatment patterns across geographies and patient subgroups

Powering global real-world evidence generation 

Draw on data from our proprietary catchment that includes 130 million+ patients from healthcare and research organizations around the world – Europe, Japan, APAC, and the Americas. We’ll apply your research objectives to identify, ingest, harmonize, and integrate the right data sources to ensure your projects are set up for success from Day One.

130M+ patients accessible 
25+ countries represented
>90% patients ex-US 
150+ data partnerships 

Shorten timelines and accelerate speed to insight

Get seamless, compliant, and secure access to research-ready RWD to support evidence generation across R&D and commercialization activities. Rich mastered data sets that include harmonized and integrated granular patient data provide the reliable foundation you need for discussions with payers, regulators, and other key stakeholders across the entire value chain

Global patient data

Explore extensive curated datasets that include clinical data, EMRs, eCRFs, labs, multi-omics, imaging data and more across oncology, neurology, rare diseases, immunology, and cardiology. And, we can easily integrate your own data to further enrich your analysis. 

Learn more
AI-powered analytics

Quickly identify patient cohorts, select biomarkers, and analyze standard of care patterns with BC Catalyst, a prompt-based precision medicine platform that makes complex genomic and real-world clinical data actionable across the entire drug lifecycle.

Learn more
Harmonized imaging data

Get standardized, large-scale imaging datasets that are research-ready and anonymized. BC Image accelerates time-to-data and enables advanced, AI-driven analytics for drug development and precision medicine.

Learn more
Flexible deployment options

Have confidence that data access is well-managed, secure and in compliance with governance standards. Commission analyses from our experts or conduct your own in a built-for-purpose trusted research environment – federated options available.

Learn more
Domain expertise

Get expert support for your trial planning and execution needs from our Scientific Services team, including protocol development and statistical analysis plans (SAP), data science services spanning epidemiology, biostatistics and programming, and medical and regulatory report writing.

Expert data harmonization and integration 

As experts in data management and stewardship, we bring proven technology, tools, and experience for processing, analyzing, and sharing sensitive data. Our data mastering platform, BC Unify, transforms and anonymizes multi-modal healthcare data — both structured and unstructured — into harmonized, standardized, analytics-ready datasets.

See how

The most comprehensive real-world data solutions

Global patient data

  • Granular attributes
  • Structured / unstructured
  • Multi-modal
  • 130M+ patient lives accessible from 25+ countries
  • 90%+ from Europe, Japan, and Asia 

Diverse datasets

  • EHRs / clinical
  • Imaging
  • Genomics / multi-omics
  • eCRFs
  • Labs
  • Biomarkers
  • And more

Longstanding partners

  • 150+ partners worldwide
  • Robust geographic distribution across urban, suburban, and rural locations

Key therapy areas

  • Oncology
  • Immunology
  • Neurology
  • Cardiology
  • Rare diseases

Curated & integrated

  • Customized to your needs
  • Harmonized and ready to use
  • Agentic AI architecture powers data mastering and integration

Flexible access

  • Direct data delivery
  • Trusted research environments (TREs)
  • Cloud or federated options

Featured news and insights

  • 3 min read

    BC Platforms launches BC Catalyst, first-to-market, AI-native analytics product that accelerates precision medicine

    BC Catalyst transforms genomic and real-world data into fast, actionable insights to advance precision medicine at scale.

    Read more
  • 2 min read

    TIME names BC Platforms as ‘Outstanding’ in World’s Top HealthTech Companies 2025 list

    Recognizing our leadership in AI, data analytics and Real-World Data.

    Read more
  • 7 min read

    How the new European Health Data Space will drive the development of AI-based tools

    BC Platforms in the press: Bio-IT World highlights our view on the role of AI in helping the European Health Data Space deliver secure, harmonized and high-value research.

    Read more
See all articles

Let’s connect to discuss your needs

Contact us to learn more about our solutions, see a live demo, or talk about how we can support your needs.  

Contact us